AnaSpec Introduces 12 New Catalog Antibodies

San Jose, CA, July 26, 2007 --(PR.com)-- Continuing in its commitment to rapidly expand its antibody offerings, AnaSpec, a leading provider of integrated proteomics solutions, added twelve (12) new antibodies to its growing collection of catalog antibodies. The targeted research area for these antibodies is signal transduction and matrix metalloproteinases.

Anti-DEFCAP (CT) - Cat# 28053, 50 µg
Host: rabbit polyclonal; Species Reactivity: human and monkey; Applications: WB

Anti-human CD4 - Cat# 53336, 50 µg
Host: rabbit polyclonal; Species Reactivity: human; Applications: WB

Anti-IkB-alpha (pSer32/36) - Cat# 29626, 50 µg
Host: rabbit polyclonal; Species Reactivity: human; mouse; rat; Applications: WB

Anti-beta-Catenin (paired 675) - Cat# 29620, 50 µg
Host: rabbit polyclonal; Species Reactivity: human; mouse; rat; Applications: WB

Anti-Tau (pSer202) - Cat# 28017, 50 µg
Host: rabbit polyclonal; Species Reactivity: human; monkey; mouse; rat; Applications: WB

Anti-CD3-epsilon - Cat# 29588, 50 µg
Host: rabbit polyclonal; Species Reactivity: human; mouse; Applications: WB; IHC

Anti-IRS-2 (pSer1100) - Cat# 29650, 50 µg
Host: rabbit polyclonal; Species Reactivity: human; mouse; Applications: WB

Anti-IRS-2 (paired1100) - Cat# 29651, 50 µg
Host: rabbit polyclonal; Species Reactivity: human; mouse; Applications: WB

Anti-p38 MAPK (CT) - Cat# 29747, 50 µg
Host: rabbit polyclonal; Species Reactivity: human; mouse; rat; Applications: WB; IHC; IP

Anti-p38 MAPK (NT) - Cat# 54419, 50 µg
Host: rabbit polyclonal; Species Reactivity: human; mouse; rat; monkey; dog; bovine; Applications: WB; IHC; IP

Anti-MMP-1 (Hinge) - Cat# 54403, 50 µg
Host: rabbit polyclonal; Species Reactivity: human; Applications: WB

Anti-MMP-13 (Hinge) - Cat# 54406, 50 µg
Host: rabbit polyclonal; Species Reactivity: human; mouse; Applications: WB

For more information visit http://www.anaspec.com/products/productcategory.asp?id=2

Company Info
AnaSpec, Inc. is a leading provider of integrated proteomics solutions to pharmaceutical, biotech, and academic research institutions throughout the world. With a vision for innovation through synergy, AnaSpec focuses on three core technologies: peptides, detection reagents, and combinatorial chemistry. Established in 1993, AnaSpec's headquarters and manufacturing facilities are located in San Jose, CA.

For more information visit www.anaspec.com

###